http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2532436-R2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf51be6339d1441fc7d473681b04add8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a016e04ae59b05b7860510d7b61c025b
publicationDate 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2532436-R2
titleOfInvention USE OF AN INDOLIC COMPOUND WITH NUCLEOPHYLL SUBSTITUTES IN C3 AND ITS DIMERIC VARIANTS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF LYMPHOID NEOPLASIAS B.
abstract Use of an indole compound with nucleophilic substituents in C3 and their dimeric variants in the preparation of a pharmaceutical composition useful for the treatment of lymphoid B neoplasms. # The present invention relates to the use of an indole compound with nucleophilic substituents in C3 and its dimeric variants, which have activity against B lymphoid neoplasms selected from among chronic lymphatic leukemia / small B cell lymphoma, and B and Hodgkin lymphomas dependent on infection by Epstein-Barr herpesvirus and which are used in the preparation of a composition pharmaceutical, which has utility for the treatment of these pathologies.
priorityDate 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027

Total number of triples: 18.